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Quality controlEukaryotic secretory pathway cargo fold to their native structures within the conﬁnes of the endoplasmic
reticulum (ER). To ensure a high degree of folding ﬁdelity, a multitude of covalent and noncovalent
constraints are imparted upon nascent proteins. These constraints come in the form of topological
restrictions or membrane tethers, covalent modiﬁcations, and interactions with a series of molecular
chaperones. N-linked glycosylation provides inherent beneﬁts to proper folding and creates a platform for
interactions with speciﬁc chaperones and Cys modifying enzymes. Recent insights into this timeline of
protein maturation have revealed mechanisms for protein glycosylation and iterative targeting of incomplete
folding intermediates, which provides nurturing interactions with molecular chaperones that assist in the
efﬁcient maturation of proteins in the eukaryotic secretory pathway.
© 2009 Elsevier B.V. All rights reserved.Anﬁnsen's seminal studies demonstrated that proteins contain all
the information in their primary sequence required to fold into their
proper three-dimensional structure [1]. Yet elevated temperatures
and protein concentrations reaching 300 mg/ml provide unfavorable
folding conditions in live cells. Strikingly, protein folding that is
reconstituted in the test tube is generally less efﬁcient than in the cell
because cells utilize alternative mechanisms, contain factors that
assist proteins in reaching their native states and destroy proteins that
fail to fold properly. Approximately one third of the entire eukaryotic
proteome is predicted to trafﬁc through the secretory pathway [2,3].
For these proteins, protein folding and maturation begin co-
translationally as the protein is translocated into the endoplasmic
reticulum (ER) lumen. The ER functions as a protein folding factory,
harboring a large array of molecular chaperones, oxidoreductases and
quality control machinery. The maturation process that includes
covalent modiﬁcations, processing, folding and assembly continues
post-translationally until the native structure is acquired. Cellular
protein folding assistance occurs via a number of constraints imparted
upon the maturing protein to streamline the folding pathway. This
results in a restriction of the vast number of possible conformations
and avoidance of off-pathway intermediates to promote the efﬁcient
acquisition of the native state. The ﬁdelity of the maturation process is
monitored by quality control machinery that sorts native proteins for
anterograde trafﬁcking and defective proteins for retention and
subsequent destruction.+1 413 545 3291.
Hebert).
ll rights reserved.1. Co-translational translocation and folding in the ER
Protein folding in living cells can begin during synthesis [4,5]. The
‘Levinthal paradox’ demonstrates that protein folding is not a random
walk since there is insufﬁcient time to sample all possible conforma-
tions available for a protein to reach its native state [6]. Protein folding
in the cell is subjected to a variety of temporal, spatial and physical
constraints, providing important restrictions that support a more
direct route to the native state. A co-translational folding process
creates a vectorial folding reaction and provides a mechanism for the
cell to control and organize the environment for the vulnerable
nascent chain [7,8]. Tethering the termini of the nascent chain to the
ribosome and themembrane further limits the freedom of the nascent
chain or the number of available folding intermediates. In addition,
the bulky ribosome separates nascent chains of a polysome, prevent-
ing nonproductive collisions or aggregation. Together, these mechan-
isms act to optimize the folding reaction in the apparent suboptimal
folding conditions within the cell.
Coupling protein folding and synthesis tapers the possible
ensemble of folding intermediates available to the shorter nascent
chains during the progression to the native state, thereby minimizing
the available nonproductive options [9]. By allowing folding to
commence co-translationally or prior to the completion of synthesis,
the amount of conformational space that may be sampled by the
nascent chain is greatly reduced, allowing short distance or local
folding events to occur ﬁrst. This early restriction in nascent chain
folding streamlines the folding pathway by reducing the conforma-
tional heterogeneity that is the result of a long fully synthesized
unfolded protein precursor [10]. In addition, by initiating folding
prior to the completion of synthesis, aggregation and non-native
Fig. 1. The composition and roles of N-linked glycans in the ER. The 14-member
carbohydrate is covalently linked to Asn residues of the consensus sequence Asn-X-Ser/
Thr as depicted. The glycan is comprised of three glucoses (triangles), nine mannoses
(circles), and two N-acetlyglucosamines (squares). The mannoses are arranged in three
branches: A, B, and C. The orientations of the glycosidic bonds are indicated. The
positions at which glucosidases I and II cleave the glucoses are designated. The glucose
that is transferred through GT1 activity and is involved in lectin chaperone binding is
highlighted. The regions of the N-glycan that are critical for chaperone interaction,
glucosidase II MRH binding, and folding kinetics are shaded.
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reduce the mobility or diffusion rate of unfolded precursors in the ER
[4,9,11]. Thus, the vectorial nature of co-translational folding helps to
fold proteins rapidly and efﬁciently.
Signal sequences on proteins destined for the ER are generally
located at the N-terminus of proteins and are ﬁrst recognized by the
cytosolic signal recognition particle (SRP) [12]. SRP delivers the
ribosome/mRNA complex to the surface of the ER through
interactions with the SRP receptor. Here, the ribosome associates
with translocon machinery, facilitating entry of the nascent chain
into the ER lumen. Protein translocation into the ER occurs through
Sec61, a large multi-protein complex that interacts with the
ribosome and allows nascent proteins to transit through its pore
[13,14]. The ribosome, Sec61 and their associated proteins can
create a privileged environment that sterically protects the nascent
chain from nonproductive interactions to favor proper protein
maturation [15].
The hydrophobic nature of signal sequences supports their
integration into ER membranes. This places a constraint on the
maturing protein by tethering its N-terminus to the membrane and
restricting the degree to which nascent chains can sample conforma-
tional space. This allows newly synthesized proteins to fold in a
controlledmanner that protects against premature folding events that
could result in nonproductive local minima until the signal sequence
is cleaved. Signal sequence cleavage is critical for proper protein
maturation. In the case of the viral envelope protein, vesicular
stomatitis virus glycoprotein G, the failure of the signal sequence to be
cleaved results in the ER retention of the misfolded viral protein [16].
The timing and efﬁciency of signal sequence cleavage is substrate
speciﬁc; though it generally appears to occur co-translationally, after
the synthesis of ∼140 amino acids [17-19]. However, the delayed
post-translational cleavage of signal sequences has been implicated in
the functional activity of a number of proteins including human
cytomegalovirus protein US11 and human immunodeﬁciency virus
glycoprotein 120 [20,21]. Furthermore, the timing of co-translational
folding events has been proposed to be dictated in part by signals
embedded within the amino acids of the signal sequence, likely
controlled by directing the timing of signal sequence cleavage and
release of the membrane tethering constraint [22].
While local structures such as α-helices have been shown to form
in the ribosome and translocon tunnels, global folding occurs upon
entrance into the ER lumen through the Sec61 translocon [5,23-26].
Covalent constraints such as disulﬁde bond formation and modiﬁca-
tion with sugar chains occur as proteins are being synthesized, and
these modiﬁcations can also signiﬁcantly contribute to the efﬁcient
maturation of secretory cargo [5,27].
2. N-linked glycosylation
The glycosidic linkage of preformed 14-member carbohydrate
chains onto Asn residues in the consensus sequence Asn-X-Ser/Thr
(where X can be any amino acid except Pro) are added to the majority
of proteins that traverse the secretory pathway [28-30]. Glycans can
greatly impact the folding of these proteins. The N-linked glycan is
comprised of twoN-acetyl glucosamines (GlcNAc) and ninemannoses
(Man) arranged in three branches (A, B, and C) with three glucoses
(Glc) attached to the A-branchmannose residue (Fig. 1). The N-glycan
is transferred preassembled from dolichol-P-linked lipids by the
oligosaccharyltransferase (OST) that is associated with the Sec61
translocon (Fig. 2, step 1) [28]. There are two forms of the OST that
contain different isoforms of the catalytic subunit, STT3 [31]. A recent
study has shown that the STT3A-containing OST can support co-
translational glycosylation of nascent glycoprotein substrates, where-
as the STT3B isoform can additionally facilitate the post-translational
glycosylation of substrates [32]. These results suggest that the
addition of glycans does not necessarily occur in linear succession.In addition, the OST subunit Ost3/6p has been found to contain an
active thioredoxin-like domain possessing oxidoreductase activity
[33]. Since oxidation of substrate proteins has been shown to
negatively impact glycosylation efﬁciency [34,35], the covalent
tethering of nascent chains to the Ost3/6p subunit can impact
glycosylation transfer efﬁciency [33].
The addition of N-glycans to nascent proteins has an immediate
effect on the folding pathway of the substrate and its eventual fate. N-
glycans are highly ﬂexible and hydrophilic structures that mask
hydrophobic stretches on proteins and greatly impacting the
sampling of conformational space during folding [36,37]. Examples
are available that demonstrate the intrinsic effects of glycosylation on
protein stability and oligomerization, with glycans providing a
chaperone-like effect on protein folding [38]. N-glycans have been
shown to prevent the undesired association of hydrophobic stretches,
which can lead to aggregation [39,40]. Indeed, glycosylation has been
implicated in maintaining the prion protein in a non-ﬁbril conforma-
tion [41]. The ﬂexibility of N-glycans is exploited to protect proteins
from proteases and shield pathogens from immune detection [42-44].
Recent studies have revealed tight interactions between the base
trisaccharide core (Man1GlcNAc2) and the folding polypeptide that
impacts the kinetics of protein folding [45]. The majority of this
contribution to protein folding thermodynamics and kinetics is
actually derived from the single innermost GlcNAc residue. Analysis
of the of the Human Gene Mutation Database has revealed that gain-
of-glycosylation mutations occur in a much higher prevalence than
previously anticipated, while mutation of glycosylation consensus
sites are rarer than predicted [46]. This ﬁnding highlights the positive
inﬂuence of the inherent properties of glycans on protein folding in
the cell. The mutational introduction of a glycosylation site into a
protein can effectively destabilize the unfolded state by restricting
conformational sampling, coaxing the unfolded protein towards
native state conformations [45].
Fig. 2. Modiﬁcation of N-glycans during glycoprotein maturation. Nascent secretory proteins co-translationally enter the ER lumen. At this time, the membrane integrated
oligosaccharyltransferase (OST) transfers 14-member carbohydrates to nascent chains from lipid-linked precursors (step 1). Nearly immediately following glycan transfer, the
membrane-associated glucosidase I (Gls I) removes the terminal glucose, generating a Glc2Man9GlcNAc2 glycoform (step 2). The exposure of the second glucose allows the type I
membrane protein and lectin, malectin, to associate with nascent chains (step 3). In direct competition with malectin binding is the removal of the second glucose by glucosidase II.
Glucosidase II is comprised of an MRH domain containing β-subunit and an enzymatic α-subunit. The β-subunit MRH domain docks glucosidase II to glycoproteins via interactions
with auxiliary glycans. This in turn allows the α-subunit to remove the second glucose of the target glycan (step 4). Exposure of the innermost glucose permits interactions with the
lectin chaperones calnexin and calreticulin (step 5). However, glucosidase II competes with the lectin chaperones for binding to the substrate glycans. In this step, glucosidase II
liberates the ﬁnal glucose via docking of its MRH subunit to mannoses within the target glycan (step 6). The fully deglucosylated glycan is incapable of being bound by the lectin
chaperones and is free to fold to its native state (step 7). If non-native conformations persist, the folding sensor GT1 docks to misfolded regions and reglucosylates target glycans
(step 8). This results in reassociation with lectin chaperones for additional rounds of folding or retention (step 9). Eventually, the glucose that was added by GT1 is removed by
glucosidase II (step 10). At this point, the protein is once again free to fold to its native state. If properly folded, it will trafﬁc to its ﬁnal functional destination. It may re-enter the lectin
chaperone cycle via GT1 activity if non-native conformations remain present. If terminally misfolded, it will eventually be sorted for retrotranslocation and degradation (step 11).
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folding, glycans can also recruit folding factors to assist in protein
maturation depending upon the composition of the N-linked glycans
[29,47]. After the transfer of the 14-member carbohydrate by the OST,
the ﬁrst glucose is removed by the membrane-bound glucosidase I
(Figs. 1 and 2, step 2). This deglucosylation reaction occurs very
rapidly, since it can be detected concomitantly with glycan transfer
[48]. The Glc2Man9GlcNAc2 glycan composition prevents reassocia-
tion with the OST, acting as a commitment step to commence folding
[49,50]. Until recently, there were no known ER proteins that
interacted exclusively with the diglucosylated glycoform. However,
recent studies have identiﬁed malectin as a highly conserved ER-
localizedmembrane-bound Glc2-speciﬁc lectin with unknown roles in
glycoprotein maturation (Fig. 2, step 3) [51]. Malectin has been found
to associate with endogenous aquaporin-2 in a large-scale proteomics
study, suggestive of its involvement in glycoprotein maturation;
however, the scope of proteins that act as malectin substrates is
unknown [52]. Malectin lacks a canonical ER retention motif but
remains ER localized at steady state [51]. Thus, it is likely that malectin
is retained in the ER as a component of an unidentiﬁed complex.
Presumably, malectin acts co-translationally on substrate glycopro-
teins, since both the glycosidase action of glucosidase I that precedes
malectin binding and the subsequent trimming of glucoses by
glucosidase II can occur co-translationally [5,48]. However, there is
no direct evidence for the interaction of malectin with substrates as
they co-translationally emerge into the ER.
The diglucosylated glycan (Glc2Man9GlcNAc2) is subsequently
trimmed by glucosidase II (Fig. 1 and 2, step 4). Glucosidase II is a
soluble luminal enzyme that is comprised of an 110-kDa α-subunit
and a 60-kDa β-subunit [53]. Glucosidase activity is localized to theα-
subunit of the heterodimer, while the β-subunit in humans contains a
C-terminal HDEL ER retention signal. The glucosidase II β-subunit is
present in S. cerevisiae, yet it lacks an ER retention signal and is not
required for maintaining the localization of the α-subunit [54]. In
contrast, the β-subunit of S. pombe has a C-terminal VDEL sequence
that is important for localization of the catalytic subunit [55]. Catalytic
activity is exclusive to the α-subunit, since it alone displays in vitro
enzymatic properties [56]. Glucosidase II removes two glucoses from
glycans; hydrolysis of the Glcα1,3Glc bond to generate Glc1Man9-
GlcNAc2 glycans, and hydrolysis of the Glcα1,3Man bond to produce a
fully deglucosylated glycan (Figs. 1 and 2, steps 4 and 6). The initial
cleavage of the Glcα1,3Glc bond occurs much more rapidly than the
second cleavage of the Glcα1,3Man residues [57,58]. The Glcα1,3Glc
and Glcα1,3Man moieties are virtually indistinguishable structurally.
Rather, the differences in their catalytic cleavages are likely due to the
Glcα1,3Glc and Glcα1,3Man cleavage epitopes residing on opposite
faces of the glycan structure [48,59,60]. Since there is only a single
active site within glucosidase II, the slow and nonprocessive digestion
of the Glc1Man9GlcNAc2 glycoform is proposed to be the result of
reorientation of the active site of the α-subunit or the repositioning of
the glycosylated substrate to accommodate the opposing glycosidic
linkages.
Until recently the only function attributed to the glucosidase II β-
subunit was in the localization of the glucosidase II heterodimer to the
ER lumen via its C-terminal ER retention signal. In addition to the C-
terminal ER retention signal, the glucosidase II β-subunit contains a
Mannose-6 phosphate Receptor Homology (MRH) domain [48,61].
MRH domains are typically utilized for lectin-like interactions, as
observed for the ER resident proteins XTP3-B and OS-9 that are
involved in glycoprotein degradation [61,62]. Helenius and colleagues
observed that multiple glycans present on substrates greatly
accelerated the cleavage of the Glcα1,3Glc bond. They proposed a
model whereby the MRH domain of the β-subunit binds to a mannose
branch of a neighboring glycan to position the α-subunit in such a
way that the Glcα1,3Glc of the substrate glycan is efﬁciently
recognized and hydrolyzed (Fig. 2, step 4). Subsequently, the MRHdomain can recognize a mannose branch within the substrate glycan
to trim the ﬁnal glucose of the Glcα1,3Man linkage (Fig. 2, step 6) [48].
A detailed biochemical study revealed that the lectin interaction of the
MRH domain with substrates occurs via the C-branch mannoses [58].
This is in support of earlier work that suggested that glucosidase II
catalytic activity decreased as mannoses were removed from
substrate glycoproteins [63]. This model explains the observation
that multiple glycans were required for the transition of substrate
glycans from Glc2 to Glc1 glycoforms and that glucosidase II can
directly compete for substrate binding with other lectins in the ER
[48,58]. It is important to note that the auxiliary glycan utilized in the
transition from Glc2 to Glc1 state does not have to be localized on the
substrate glycoprotein in this model. There could be trans interactions
occurring between glycosylated maturation machinery or other
newly synthesized glycoproteins to facilitate the cleavage of the
Glcα1,3Glc bond. This model supports the ﬁndings that glucosidase II
trimming occurs in a nonprocessive manner, interrupted by critical
chaperone interactions.
Further studies highlight the importance of the β-subunit to
glucosidase II catalytic activity. The β-subunit confers substrate
speciﬁcity, is critical for the cleavage of the Glcα1,3Glc bond and is
essential for the ﬁnal digestion of the Glcα1,3Man bond to yield a fully
deglucosylated substrate, although there is evidence that S. pombe
glucosidase II α-subunit can generate fully deglucosylated substrate
in the absence of the β-subunit, albeit slowly [54,55,64,65]. The
trimming of glycans from Glc2 to Glc1 can occur in the absence of the
β-subunit; however, this cleavage is greatly accelerated in the
presence of the β-subunit [55,64]. The MRH domain of the β-subunit
is essential for this kinetic enhancement of glucose trimming and the
removal of the ﬁnal glucose since functionally deﬁcient mutations
displayed inefﬁcient and negligible conversion to the unglucosylated
state. These ﬁndings lead to an amendment to the current model for
the contribution of the β-subunit to glucosidase II activity. Previous
work has shown that the α-subunit has a greater afﬁnity for
Glc2Man9GlcNAc2 glycoforms than monoglucosylated glycans [66].
The MRH domain is critical for reorientation of the active site for the
nonprocessive hydrolysis of the Glcα1,3Glc and Glcα1,3Man bonds
[48]. In addition, the lectin-like binding of the MRH domain to the C-
branch mannoses of substrate glycoproteins greatly enhances the
kinetics of glucose trimming, enhancing the afﬁnity of the alpha
subunit for the conversion of substrates from a Glc2 to a Glc1 and
eventually a fully glucose trimmed state [55,64].
The trimming of glycoproteins from Glc2Man9GlcNAc2 to Man9-
GlcNAc2 does not occur in a processive manner. The exposure of this
innermost glucose initiates interactions with a discrete subset of
chaperones including calnexin and calreticulin that aid in the folding
of secretory glycoproteins (Figs. 1 and 2, step 5) [67-70]. The lectin
nature of theMRH domain of glucosidase II competeswith these lectin
chaperones for binding to substrates, controlling the persistency of
their protective interaction [58].
3. The lectin chaperones and their associated oxidoreductase, ERp57
Calnexin and calreticulin are glycan-dependent molecular chaper-
ones that promote proper folding in substrate proteins by stabilizing
folding events, preventing aggregation, and facilitating the catalysis of
disulﬁde bond formation [71-74]. Monoglucosylated N-linked carbo-
hydrates (Glc1ManxGlcNAc2) created by the sequential action of
glucosidases I and II are recognized by these carbohydrate-binding
chaperones (Fig. 2, step 5). Calnexin is a type I membrane protein and
is comprised of a single globular carbohydrate binding domain and an
extended proline-rich repeat domain, termed the P-domain [75].
Similarly, calreticulin contains both a carbohydrate binding and P-
domain, but is a soluble protein with a C-terminal ER retention motif
[76,77]. These chaperones bind monoglucosylated proteins in a Ca2+-
dependent fashion [75,78,79]. Binding of the lectin chaperones aids in
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occur in a controlled manner [69,71]. This is also evident from studies
in calnexin and calreticulin deﬁcient cell lines, where folding was
found to be accelerated; however, the subsequent folding efﬁciency
was diminished [80].
Lectin chaperone association represents a critical constraint for
glycoprotein folding. Studies using ribosome-arrested chains have
found that there is a predetermined order of events when nascent
glycoproteins ﬁrst enter the ER lumen through the Sec61 translo-
con. The membrane-bound calnexin is found in close association
with the translocon complex. Phosphorylation of the cytoplasmi-
cally exposed C-terminal tail of calnexin has been proposed to
regulate its association with the ribosome/translocon complex [81].
Calnexin interacts initially with the nascent chain, while associa-
tions with the soluble calreticulin can closely follow depending
upon the organization of glycans on the substrate [18,19]. There is
also a coupling between the lectin chaperone system and BiP, the
ER-resident Hsp70 family member. BiP interacts with hydrophobic
stretches of newly synthesized protein prior to the addition of
hydrophilic N-glycans [19,82]. The distance the glycans are located
from the N-terminus can dictate whether BiP initially interacts with
a nascent chain co-translationally [83]. BiP is less likely to be
involved in the maturation of glycoproteins that contain glycans
near the N-terminus since they are hydrophilic thus inhibitory for
BiP binding and they support the early diversion to the lectin
chaperone system [19,83,84].
The topology of the lectin chaperones and their substrate is also
involved in determining which chaperones bind a particular sub-
strate. Calnexin is situated to interact with membrane proximal
glycans, either onmembrane-associated proteins or with proteins still
entering the ER lumen. Since calreticulin is a soluble protein, it is
organized to interact with glycans that emerge deeper into the ER
lumen, on either membrane or soluble substrates [85-87].
The lectin chaperones can also facilitate disulﬁde bond formation
and isomerization on substrate proteins via their noncovalent
association with the oxidoreductase ERp57 [73,74,88,89]. ERp57 is
an ER resident protein disulﬁde isomerase family member with four
thioredoxin domains, two of which contain catalytic Cys pairs. It docks
on the lectin chaperones through an interaction of a positively
charged patch on a noncatalytic thioredoxin domain and the
negatively charged tip of the extended P-domain of the lectin
chaperones [76]. It is thought that there is very little free ERp57 in
the ER lumen since it predominantly exists in a 1:1 association with
each lectin chaperone. In addition, there is a secondary pool
associated with tapasin, a protein involved in class I antigen assembly
and processing, however this localization appears to be independent
of ERp57 redox function [90-92].
Disulﬁde bond formation represents an additional constraint
imparted upon nascent glycoproteins during co-translational fold-
ing. Disulﬁdes can limit the conformational ﬂexibility, increase
structural rigidity and stabilize proteins once they are exposed to
the harsh extracellular environment. Disulﬁdes can also be used as
transitory elements during folding, ensuring that a critical folding
intermediate is reached, and subsequently isomerized to achieve
native conformations [93,94]. In conjunction with the lectin
chaperones, ERp57 can perform oxidation, reduction, and isomer-
ization reactions of Cys pairs in glycoprotein substrates [95]. ERp57
has been found mainly in a reduced form in cells at steady state
[96,97]. The reduced form can only perform isomerization and
reduction reactions for substrate proteins. However, it has been
found associated with ERO1α, the protein that generates oxidizing
equivalents in the ER, and ERp57 has been shown to possess
oxidase activity in vivo, suggesting that it is a fully functional
oxidoreductase [95,98]. While the deletion of ERp57 is not lethal to
cells, it is essential for mouse development as knockout animals die
in utero [99,100]. There could be multiple PDI family proteins thatcan substitute for ERp57 in its absence, since there are currently
nearly 20 ER-resident members [101]. In recent studies of ERp57, it
has been shown to be intimately involved in the late-stage
rearrangement of disulﬁdes in complex glycoproteins [100]. This
highlights an additional mode of glycoprotein folding that occurs
after nascent proteins have fully emerged into the ER lumen.
The folding of glycoproteins generally occurs, at least for distal
interactions, after their release from the lectin chaperones that is
triggered by glucosidase II-mediated cleavage of the ﬁnal glucose
[69,71]. Glycoproteins that have failed to achieve their native
conformations following their release into the ER lumen are
subjected to a quality control process [30,102]. If non-native
conformations persist, the quality control sensor GT1 (UDP-glucose:
glycoprotein glucosyltransferase 1) detects these instabilities and
transfers a glucose back onto deglucosylated glycoproteins, regener-
ating monoglucosylated glycans (Fig. 2, step 8) [103-106]. These
reglucosylated substrates then re-associate with the lectin chaper-
ones and ERp57 to reinitiate folding events in a process termed the
‘calnexin cycle’ (Fig. 2, step 9) [68-70,104]. Persistent binding to the
lectin chaperones assists protein folding, prevents aggregation
through sequestration, retains immature or unassembled structures
in the ER and potentially aids in the sorting of malformed substrates
for degradation [72,107-109].
4. GT1 reglucosylation and quality control of
glycoprotein maturation
GT1 is a primary folding or quality control sensor of the ER. It is
currently the only known ER enzyme that alters the glycan
composition of a protein based on structural features of the modiﬁed
protein [104-106,110-112]. In vitro studies have revealed that GT1
detects malformed glycoproteins via surface-exposed hydrophobic
patches, indicative of protein immaturity or misfolding [104,106]. The
selectivity of GT1 for exposed hydrophobic stretches in substrate
proteins allows for discrete malformed regions to be modiﬁed by
reglucosylation of proximal glycans, addressing protein misfolding at
the domain level (Fig. 3B, steps 3 and 4) [110,113]. Biophysical studies
have demonstrated that GT1 targets nearly native molten globule
proteins [111,114]. GT1 has the ability to distinguish minor structural
perturbations, since in vitro reglucosylation increases signiﬁcantly
with the introduction of aberrant structures [113,115]. In addition,
GT1 substrates may not necessarily be malformed at the level of
monomers, since GT1 can target and reglucosylate orphan oligomeric
subunits of soybean agglutinin that exhibit native conformations in
vitro [116]. Finally, a cellular study revealed that the folding sensor
capabilities of GT1 can function in the case of natively folding
substrate or when protein folding is transiently or terminally
disrupted (Fig. 3B, steps 6 and 7) [117].
GT1 is a 174-kDa glycoprotein comprised of two main functional
domains [118,119]. The N-terminal domain of GT1 contains nearly
75% of its primary sequence and functions as the sensor of substrate
misfolding, while the C-terminal domain contains the glucosyltrans-
ferase catalytic activity. The C-terminal domain is highly conserved
amongst species (65%) and is homologous to proteins of the
glycosyltransferase family 8 (Fig. 3A). The large N-terminal domain
has a much lower similarity between species that may indicate a
means of substrate selection, however domain swapping experiments
of the S. pombe and D. melanogaster glucosyltransferases resulted in
functional reglucosylation activity on misfolded substrates [119].
Despite numerous efforts, a structure of GT1 remains elusive.
GT1 catalyzes the transfer of glucose from the donor UDP-glucose
to the terminal A branch mannose of misfolded glycoproteins,
regenerating the Glcα1,3Man signal (Fig. 1) [120]. This step occurs
after the initial recognition of misfolding, as determined by in vitro
competition assays, where saturating levels of nonglycosylated
misfolded protein could prevent reglucosylation of a glycosylated
Fig. 3.Model of GT1 reglucosylation of a malformed glycoprotein. (A) Schematic representation of human GT1. Human GT1 is a 174-kDa protein with the mature protein consisting
of 1531 amino acids after signal sequence cleavage. The N-terminus contains the protein recognition folding sensor domain, which represents 75% of the primary sequence and the
cleavable signal sequence (black). The C-terminal domain contains the catalytic glucosyltransferase activity and the ER-retention signal R-E-E-L. In addition, the positioning of the
two hypothetical glycosylation sites in human GT1 are depicted as dashed lines and Cys residues are marked with red ovals. The Asp-X-Asp motif is shown in the C-terminal domain
(D×D). (B) Schematic of GT1-mediated reglucosylation in the ER. Glycoproteins are extracted from the lectin chaperone cycle by glucosidase II, which removes the last glucose in the
A-branch (step 1). The chaperone released protein can attempt to fold to its native state, with certain domains being properly folded (triangle) and others being non-native or
malformed (star) (step 2). GT1 can reglucosylate glycans situated near these non-native domains through docking to exposed hydrophobic patches (step 3). The substrate
glycoprotein is now monoglucosylated (step 4). The newly reglucosylated protein can re-enter the calnexin and calreticulin binding cycle (step 5). The afﬁnity of the lectin
chaperones will decrease as the glycan is further trimmed by mannosidases and the protein will either be able to attain its native functional form (step 6) or be designated for
degradation (step 7).
689B.R. Pearse, D.N. Hebert / Biochimica et Biophysica Acta 1803 (2010) 684–693substrate [113]. Regions near the C-terminus of GT1 were found to be
strictly conserved amongst species and other glycosyltransferase
enzymes. Mutation of the Asp-X-Asp motif, an amino acid sequence
critical for glycosyltransferase activity nearly completely inhibited
reglucosylation (Fig. 3A) [121,122]. Initially, it was believed that the
Asp-X-Aspmotif was not involved in catalysis; rather it was utilized in
binding the UDP-glucose donor. However, recent evidence from
studies on other glycosyltransferases has revealed that the Asp-X-Asp
motif is involved in metal coordination that is required for UDP-sugar
docking and indirectly enhances catalytic activity [123]. The actual
catalytic residues of GT1 are currently uncertain. In order to complete
the transferase reaction, GT1 docks to the base N-acetylglucosamine
and inmore detailed chemical assays, has been shown to interact with
the Man1GlcNAc2 base unit [105,124].Both mice and humans have two distinct isoforms of the glucosyl-
transferase termed GT1 and GT2 [125]. Human GT1 and GT2 share 55%
identity in their amino acid sequences; however, the majority of this
high degree of identity is localized to the C-terminal catalytic domain
(83%) [118,125]. The cellular localization of GT1 and GT2 is identical
when overexpressed, but differences arise in their ability to reglucosy-
late misfolded glycoproteins. Functional protein chimeras created from
the N-and C-terminal domains of GT1 and GT2 only resulted from the
combination of the GT1 N-terminal domain and either the C-terminal
catalytic regionofGT1orGT2 [118]. BothGT1andGT2have the ability to
facilitate glucose transfer but only GT1 displays an afﬁnity for misfolded
conformers of substrate proteins. Additionally, only GT1 expression is
upregulated by the unfolded protein response (UPR), supporting the
importance of GT1 for protein folding in the ER [118,125].
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implications in its function. Unstable non-native conformers can have
deleterious effects on the successful maturation of newly synthesized
proteins in the active folding environment. Thus, it is likely that the
‘calnexin cycle’ takes place in an environment somewhat secluded, so
that active folding events can continue uninterrupted. GT1 regluco-
sylation occurs post-translationally, placing its activity outside of the
crowded conﬁnes of the ER translocon (Fig. 2, step 8 and Fig. 3B)
[117]. GT1 has been localized to late stage folding suborganellar
regions in the ER by indirect immunoelectron microscopy and
quantitative proteomics [126,127]. Since not all substrates modiﬁed
by GT1 are capable of achieving a native fold, it would be beneﬁcial for
degradation machinery to reside in a similar locale. Indeed, a
component of the putative retrotranslocon pore, Derlin-1, is also
primarily located in smooth ER membranes [127].
GT1 may not act alone in glycoprotein quality control as recently a
selenocysteine-containing oxidoreductase of 15-kDa (Sep15) was
found to bind GT1 with high afﬁnity in a 1:1 complex (Kdb 20 nM).
GT1 and Sep15 also appear to share a common subcellular localization
and the ability to be transcriptionally upregulated by stress [127,128].
The binding of Sep15 to GT1 does not involve any of its catalytic
oxidoreductase residues, potentially leaving these available for
interaction with GT1 substrates [129,130]. A role for Sep15 in
rearranging non-native disulﬁde bonds in an effort to reduce
complications for the calnexin cycle can be envisioned. In addition,
the combination of the misfolding sensor capabilities of GT1 and the
reduction activity of Sep15 could be involved in preparing terminally
malformed proteins for degradation.
The positioning of glycans on a substrate is important for both
lectin chaperone binding and GT1-mediated reglucosylation. In vitro
studies using a glycopeptide library found that GT1 reglucosylation
occurred most frequently on glycopeptides that contained dual
proximal hydrophobic patches located C-terminal to the glycan
[112]. A more recent in vitro study used synthetic glycans and
substrates to demonstrate that moving the hydrophobic moiety
closer to the glycosylation site increased GT1 activity [124]. A cellular
study determined that GT1 speciﬁcally targeted glycans located on
the membrane proximal slow folding domain of inﬂuenza hemag-
glutinin to direct lectin chaperone post-translational rebinding to the
immature or aberrant region [117]. GT1 can utilize this quality
control selection process to play roles in assisting native protein
folding events, triggering prolonged chaperone interactions in
difﬁcult to fold regions (Fig. 3B, step 4). Additionally, it can drive
persistent chaperone association to retain misfolded proteins for
additional rounds of folding or delivery to degradation machinery.
This adaptability and response towards many folding situations is
why GT1 is so critical to secretory protein maturation in higher order
organisms and likely explains why its knockout is embryonic lethal
in mice [131,132]. However, GT activity is not found in all organisms
as it is missing in S. cerevisiae [133]. There is likely a restricted
population of proteins that require an intact lectin chaperone
binding cycle and some of these proteins might be needed for
animal development and survival. The complexity and load of
secretory cargo of multicellular organisms far exceeds that for
unicellular organisms. Extracellular materials are frequently large
complex multidomain glycosylated proteins with intricate disulﬁde
networks. These types of proteins are strong candidates for utilizing
and requiring an intact lectin chaperone binding cycle for efﬁciently
acquiring their native states.
Outlook
The proper folding of secretory proteins within the conﬁnes of the
ER is governed by a number of covalent and noncovalent constraints
that guide the protein towards native state conformations. The
trimming of glucoses from the N-glycans of glycoproteins triggers acascade of assistive interactions with chaperones and their associated
oxidoreductase. One recently discovered lectin, malectin, provides an
interesting example of temporal interactions with glycosylated
substrates. Malectin interacts with Glc2 glycoforms, a glycan moiety
that was thought previously to either be inert during protein
maturation or provide a delay before binding to calnexin and
calreticulin. It will be important to determine if malectin interacts
with substrates co-translationally, and how its role in preceding
calnexin and calreticulin binding assists glycoprotein folding.
The cleavage of mannoses also occurs in the ER. In functional
contrast to the relation of glucose trimming to folding, loss of
mannoses is thought to act as a signal for targeting for transport or
degradation [29,47,134,135]. A model whereby mannose trimming
signals for degradation is attractive, since mannose-trimmed glyco-
forms display a decreased afﬁnity for the machinery associated with
proper folding, such as glucosidase II, the lectin chaperones, and GT1
[55,64,105,136,137]. However, recent studies have revealed that the
mannose trimming may also occur on the quality control machinery,
providing an indirect signal for localizing an aberrant substrate that is
bound to an ERAD receptor to be recruited by the membrane
retrotranslocation machinery [138-140].
Recent studies have elucidated a further level of complexity in the
involvementofMRHdomains inglycoproteinmaturation. Theβ subunit
of glucosidase II contains anMRHdomain that binds fullymannosylated
glycoforms [64]. However, the quality control degradation receptorsOS-
9 and XTP3-B utilize MRH domains to bind mannose-trimmed species
en route to proteasomal degradation [138,141-143]. How these MRH
domains are functionally distinct remains unclear, since mutations of
conserved residues are detrimental to the binding capacity of both
classes of MRH domain-containing proteins.
The effect of glycans on protein folding is location dependent. The
discrete positioning of glycans along the polypeptide chain to aid in
vectorial folding is an overlooked determinant for proper folding.
Speciﬁc glycans amongst an array of glycans localized on a substrate
can elicit isolated lectin chaperone association or trigger the
degradation process [86,144,145]. In addition, glycans can be
evolutionarily selected to reside near critical Cys residues to prevent
nonnative covalent association and recruit the glycoprotein-speciﬁc
oxidoreductase ERp57 to the site of oxidation [18]. The situation of
glycosylation consensus sites near Cys residues can also control the
efﬁciency of glycan transfer by the OST, affecting further downstream
folding events [33].
The ER is the nexus of secretory protein folding in the cell. The
constraints imparted on protein folding pathways within this
organelle ensure a high stringency for selection of properly formed
functional folds to maintain essential cellular processes and viability.
Understanding the organization of the cellular machinery in the ER
responsible for eliciting these constraints using improved high-
resolution microscopy techniques will provide valuable insight into
how the spatial organization of the ER helps control the temporal
associations with nascent chains along the maturation assembly line.
Advances in our understanding of the regulation and administration
of covalent and noncovalent constrictions during protein maturation
in the ER will further our knowledge of these processes and provide
insight into how they can be manipulated to provide potential
therapies for protein misfolding diseases.
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